{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:07:22Z","timestamp":1794344842135,"version":"4.9.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:p>Secretory carcinoma (SC) of the salivary glands is a low-grade carcinoma characterized by a well-defined morphology and immunohistochemical features. <jats:italic toggle=\"yes\">ETV6-NTRK3<\/jats:italic> fusions are detected in the great majority of SCs. Recently, other partners fused to <jats:italic toggle=\"yes\">ETV6<\/jats:italic> have been documented in a small portion of SCs, suggesting the presence of alternative genetic fusion. In this study, we examined the genetic fusion of 9 SCs using fluorescence in situ hybridization, reverse transcription-polymerase chain reaction, and next-generation sequencing (ArcherDx). Classic <jats:italic toggle=\"yes\">ETV6<\/jats:italic> exon 5<jats:italic toggle=\"yes\">-NTRK3<\/jats:italic> exon 15 fusion was detected in 8 of 9 SCs. The remaining tumor was negative for the <jats:italic toggle=\"yes\">ETV6-NTRK3<\/jats:italic> fusion but harbored a novel fusion, <jats:italic toggle=\"yes\">CTNNA1<\/jats:italic> exon 11<jats:italic toggle=\"yes\">-ALK<\/jats:italic> in exon 20. Immunohistochemically, pan-TRK was positive in 8 tumors with <jats:italic toggle=\"yes\">ETV6-NTRK3<\/jats:italic> fusion but negative in an <jats:italic toggle=\"yes\">ALK<\/jats:italic>-rearranged SC, while ALK was positive only in the <jats:italic toggle=\"yes\">ALK<\/jats:italic>-rearranged tumor. Histologically, the <jats:italic toggle=\"yes\">ALK<\/jats:italic>-rearranged tumor showed dominant macrocystic architecture. In conclusion, we found a case of SC with <jats:italic toggle=\"yes\">CTNNA1-ALK<\/jats:italic> fusion. Because <jats:italic toggle=\"yes\">ALK<\/jats:italic> fusion after exon 20 on the ALK side (upstream of the tyrosine kinase domain) has been reported to activate a carcinogenic kinase in various <jats:italic toggle=\"yes\">ALK<\/jats:italic>-rearranged tumors, ALK inhibitors may be a possible therapeutic option for <jats:italic toggle=\"yes\">ALK<\/jats:italic>-rearranged SC. In addition, ALK immunohistochemistry can be a screening tool for <jats:italic toggle=\"yes\">ALK<\/jats:italic>-rearranged SC. This study also expands the molecular spectrum of this tumor beyond the <jats:italic toggle=\"yes\">ETV6<\/jats:italic> gene.<\/jats:p>","DOI":"10.1097\/pas.0000000000001471","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T04:30:40Z","timestamp":1585024240000},"page":"962-969","source":"Crossref","is-referenced-by-count":40,"title":["Salivary Secretory Carcinoma Harboring a Novel ALK Fusion"],"prefix":"10.1097","volume":"44","author":[{"given":"Eiichi","family":"Sasaki","sequence":"first","affiliation":[{"name":"Pathology and Molecular Diagnostics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"Masago","sequence":"additional","affiliation":[{"name":"Pathology and Molecular Diagnostics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Fujita","sequence":"additional","affiliation":[{"name":"Pathology and Molecular Diagnostics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Head and Neck Surgery, Aichi Cancer Center Hospital, Nagoya, Aichi Prefecture, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Hanai","sequence":"additional","affiliation":[{"name":"Head and Neck Surgery, Aichi Cancer Center Hospital, Nagoya, Aichi Prefecture, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waki","family":"Hosoda","sequence":"additional","affiliation":[{"name":"Pathology and Molecular Diagnostics"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,3,20]]},"reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0b013e3181d9efcc","article-title":"Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity","volume":"34","author":"Skalova","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1535-6108(02)00180-0","article-title":"Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma","volume":"2","author":"Tognon","year":"2002","journal-title":"Cancer Cell"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/PAS.0000000000000537","article-title":"Mammary analogue secretory carcinoma of salivary glands: molecular analysis of 25 ETV6 gene rearranged tumors with lack of detection of classical ETV6-NTRK3 fusion transcript by standard RT-PCR: report of 4 cases harboring ETV6-X gene fusion","volume":"40","author":"Skalova","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/PAS.0000000000000392","article-title":"Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic and molecular study including 2 cases harboring ETV6-X fusion","volume":"39","author":"Ito","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/PAS.0000000000000972","article-title":"Molecular profiling of mammary analog secretory carcinoma revealed a subset of tumors harboring a Novel ETV6-RET translocation: report of 10 cases","volume":"42","author":"Skalova","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/PAS.0000000000001065","article-title":"Salivary secretory carcinoma with a novel ETV6-MET fusion: expanding the molecular spectrum of a recently described entity","volume":"42","author":"Rooper","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1158\/1078-0432.CCR-10-0851","article-title":"Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment","volume":"16","author":"Camidge","year":"2010","journal-title":"Clin Cancer Res"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.humpath.2019.03.004","article-title":"The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement","volume":"88","author":"Dogan","year":"2019","journal-title":"Hum Pathol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41467-017-01178-z","article-title":"Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions","volume":"8","author":"Dalin","year":"2017","journal-title":"Nat Commun"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.humpath.2014.09.012","article-title":"Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers","volume":"46","author":"Urano","year":"2015","journal-title":"Hum Pathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/modpathol.2012.57","article-title":"DOG1: a novel marker of salivary acinar and intercalated duct differentiation","volume":"25","author":"Chenevert","year":"2012","journal-title":"Mod Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/PAS.0000000000001309","article-title":"Macrocystic (mammary analogue) secretory carcinoma: an unusual variant and a pitfall in the differential diagnosis of cystic lesions in the head and neck","volume":"43","author":"Hernandez-Prera","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/PAS.0000000000000952","article-title":"Recurrent RET gene rearrangements in intraductal carcinomas of salivary gland","volume":"42","author":"Weinreb","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/PAS.0000000000001133","article-title":"Molecular profiling of salivary gland intraductal carcinoma revealed a subset of tumors harboring NCOA4-RET and novel TRIM27-RET fusions: a report of 17 cases","volume":"42","author":"Skalova","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/PAS.0000000000001301","article-title":"NCOA4-RET and TRIM27-RET are characteristic gene fusions in salivary intraductal carcinoma, including invasive and metastatic tumors: is \u201cintraductal\u201d correct?","volume":"43","author":"Skalova","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/PAS.0b013e3182233e06","article-title":"Comprehensive histologic analysis of ALK-rearranged lung carcinomas","volume":"35","author":"Yoshida","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1158\/1078-0432.CCR-15-3000","article-title":"Oncogenic ALK fusion in rare and aggressive subtype of colorectal adenocarcinoma as a potential therapeutic target","volume":"22","author":"Yakirevich","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1158\/2159-8290.CD-12-0009","article-title":"ALKoma: a cancer subtype with a shared target","volume":"2","author":"Mano","year":"2012","journal-title":"Cancer Discov"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/modpathol.2017.32","article-title":"Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas","volume":"30","author":"Krings","year":"2017","journal-title":"Mod Pathol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.semcancer.2005.01.003","article-title":"ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages","volume":"15","author":"Lannon","year":"2005","journal-title":"Semin Cancer Biol"},{"key":"R21-20230922","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081074","article-title":"The transcriptional roles of ALK fusion proteins in tumorigenesis","volume":"11","author":"Ducray","year":"2019","journal-title":"Cancers (Basel)"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1038\/s41467-018-07341-4","article-title":"RET rearrangements are actionable alterations in breast cancer","volume":"9","author":"Paratala","year":"2018","journal-title":"Nat Commun"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1200\/JCO.2012.43.9422","article-title":"MET as a possible target for non-small-cell lung cancer","volume":"31","author":"Sadiq","year":"2013","journal-title":"J Clin Oncol"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jtho.2018.12.003","article-title":"Expanding the molecular characterization of thoracic inflammatory myofibroblastic tumors beyond ALK gene rearrangements","volume":"14","author":"Chang","year":"2019","journal-title":"J Thorac Oncol"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/PAS.0000000000000677","article-title":"ETV6-NTRK3 is expressed in a subset of ALK-negative inflammatory myofibroblastic tumors","volume":"40","author":"Alassiri","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/path.4152","article-title":"An alpha-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer","volume":"229","author":"Majewski","year":"2013","journal-title":"J Pathol"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood.V89.4.1394","article-title":"Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1","volume":"89","author":"Pulford","year":"1997","journal-title":"Blood"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1097\/PAS.0000000000001366","article-title":"Pan-TRK Immunohistochemistry: a useful diagnostic adjunct for secretory carcinoma of the breast","volume":"43","author":"Harrison","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/his.13981","article-title":"Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool in diagnosing secretory carcinoma of salivary gland and detecting ETV6-NTRK3 fusion","volume":"76","author":"Xu","year":"2020","journal-title":"Histopathology"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00428-019-02640-7","article-title":"Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland","volume":"476","author":"Bell","year":"2020","journal-title":"Virchows Arch"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1097\/PAS.0000000000000911","article-title":"Pan-Trk immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions","volume":"41","author":"Hechtman","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12105-014-0557-1","article-title":"Morphology in conjunction with immunohistochemistry is sufficient for the diagnosis of mammary analogue secretory carcinoma","volume":"9","author":"Shah","year":"2015","journal-title":"Head Neck Pathol"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.humpath.2018.08.011","article-title":"Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family","volume":"83","author":"Guilmette","year":"2019","journal-title":"Hum Pathol"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/PAS.0000000000001261","article-title":"Secretory carcinoma of the skin: report of 6 cases, including a case with a novel NFIX-PKN1 translocation","volume":"43","author":"Kastnerova","year":"2019","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T23:06:45Z","timestamp":1695424005000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001471"}},"subtitle":["Expanding the Molecular Characterization of Carcinomas Beyond the ETV6 Gene"],"short-title":[],"issued":{"date-parts":[[2020,3,20]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001471","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,20]]}}}